Literature DB >> 24100951

Radio-sensitization of human leukaemic MOLT-4 cells by DNA-dependent protein kinase inhibitor, NU7441.

Ales Tichy1, Kamila Durisova, Barbora Salovska, Jaroslav Pejchal, Lenka Zarybnicka, Jirina Vavrova, Natalie A Dye, Zuzana Sinkorova.   

Abstract

We studied the effect of pre-incubation with NU7441, a specific inhibitor of DNA-dependent protein kinase (DNA-PK), on molecular mechanisms triggered by ionizing radiation (IR). The experimental design involved four groups of human T-lymphocyte leukaemic MOLT-4 cells: control, NU7441-treated (1 μM), IR-treated (1 Gy), and combination of NU7441 and IR. We used flow cytometry for apoptosis assessment, Western blotting and ELISA for detection of proteins involved in DNA repair signalling and epifluorescence microscopy for detection of IR-induced phosphorylation of histone H2A.X. We did not observe any major changes in the amount of DNA-PK subunits Ku70/80 caused by the combination of NU7441 and radiation. Their combination led to an increased phosphorylation of H2A.X, a hallmark of DNA damage. However, it did not prevent up-regulation of neither p53 (and its phosphorylation at Ser 15 and 392) nor p21. We observed a decrease in the levels of anti-apoptotic Mcl-1, cdc25A phosphatase, cleavage of PARP and a significant increase in apoptosis in the group treated with combination. In conclusion, the combination of NU7441 with IR caused increased phosphorylation of H2A.X early after irradiation and subsequent induction of apoptosis. It was efficient in MOLT-4 cells in 10× lower concentration than the inhibitor NU7026. NU7441 proved as a potent radio-sensitizing agent, and it might provide a platform for development of new radio-sensitizers in radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24100951     DOI: 10.1007/s00411-013-0494-5

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  30 in total

1.  Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination.

Authors:  Michele Tavecchio; Joanne M Munck; Celine Cano; David R Newell; Nicola J Curtin
Journal:  Cancer Chemother Pharmacol       Date:  2011-06-01       Impact factor: 3.333

2.  Potent enantioselective inhibition of DNA-dependent protein kinase (DNA-PK) by atropisomeric chromenone derivatives.

Authors:  Kate M Clapham; Tommy Rennison; Gavin Jones; Faye Craven; Julia Bardos; Bernard T Golding; Roger J Griffin; Karen Haggerty; Ian R Hardcastle; Pia Thommes; Attilla Ting; Céline Cano
Journal:  Org Biomol Chem       Date:  2012-07-19       Impact factor: 3.876

Review 3.  Involvement of DNA-PK and ATM in radiation- and heat-induced DNA damage recognition and apoptotic cell death.

Authors:  Masanori Tomita
Journal:  J Radiat Res       Date:  2010-08-28       Impact factor: 2.724

Review 4.  Ataxia-telangiectasia mutated kinase (ATM) as a central regulator of radiation-induced DNA damage response.

Authors:  Ales Tichý; Jirina Vávrová; Jaroslav Pejchal; Martina Rezácová
Journal:  Acta Medica (Hradec Kralove)       Date:  2010

5.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.

Authors:  D W Nicholson; A Ali; N A Thornberry; J P Vaillancourt; C K Ding; M Gallant; Y Gareau; P R Griffin; M Labelle; Y A Lazebnik
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

Review 6.  DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis.

Authors:  Carol Bernstein; Harris Bernstein; Claire M Payne; Harinder Garewal
Journal:  Mutat Res       Date:  2002-06       Impact factor: 2.433

7.  CDK9 phosphorylates p53 on serine residues 33, 315 and 392.

Authors:  Senthil K Radhakrishnan; Andrei L Gartel
Journal:  Cell Cycle       Date:  2006-03-01       Impact factor: 4.534

8.  Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441.

Authors:  Yan Zhao; Huw D Thomas; Michael A Batey; Ian G Cowell; Caroline J Richardson; Roger J Griffin; A Hilary Calvert; David R Newell; Graeme C M Smith; Nicola J Curtin
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

9.  Targeting the DNA double strand break repair machinery in prostate cancer.

Authors:  Fadhel S Shaheen; Pawel Znojek; Ann Fisher; Martin Webster; Ruth Plummer; Luke Gaughan; Graeme C M Smith; Hing Y Leung; Nicola J Curtin; Craig N Robson
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

10.  Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition.

Authors:  I Hoffmann; G Draetta; E Karsenti
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

View more
  9 in total

1.  Making radiation therapy more effective in the era of precision medicine.

Authors:  Xingchen Peng; Zhigong Wei; Leo E Gerweck
Journal:  Precis Clin Med       Date:  2020-12-01

2.  Inhibition of DNA‑PK activity sensitizes A549 cells to X‑ray irradiation by inducing the ATM‑dependent DNA damage response.

Authors:  Lina Yang; Xinrui Yang; Yiwei Tang; Defu Zhang; Lijie Zhu; Shengnan Wang; Bo Wang; Tao Ma
Journal:  Mol Med Rep       Date:  2018-03-29       Impact factor: 2.952

3.  Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 Status.

Authors:  Hind Hafsi; Magnus T Dillon; Holly E Barker; Joan N Kyula; Ulrike Schick; James T Paget; Henry G Smith; Malin Pedersen; Martin McLaughlin; Kevin J Harrington
Journal:  Front Oncol       Date:  2018-07-13       Impact factor: 6.244

Review 4.  Targeting DNA repair pathway in cancer: Mechanisms and clinical application.

Authors:  Manni Wang; Siyuan Chen; Danyi Ao
Journal:  MedComm (2020)       Date:  2021-12-07

Review 5.  Preventing Damage Limitation: Targeting DNA-PKcs and DNA Double-Strand Break Repair Pathways for Ovarian Cancer Therapy.

Authors:  Daniela A Dungl; Elaina N Maginn; Euan A Stronach
Journal:  Front Oncol       Date:  2015-10-26       Impact factor: 6.244

Review 6.  DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of Cancer.

Authors:  Denis Velic; Anthony M Couturier; Maria Tedim Ferreira; Amélie Rodrigue; Guy G Poirier; Fabrice Fleury; Jean-Yves Masson
Journal:  Biomolecules       Date:  2015-11-20

7.  Inactivation of DNA-PK by knockdown DNA-PKcs or NU7441 impairs non-homologous end-joining of radiation-induced double strand break repair.

Authors:  Jun Dong; Yufeng Ren; Tian Zhang; Zhenyu Wang; Clifton C Ling; Gloria C Li; Fuqiu He; Chengtao Wang; Bixiu Wen
Journal:  Oncol Rep       Date:  2018-01-16       Impact factor: 3.906

8.  Radio-sensitizing effects of VE-821 and beyond: Distinct phosphoproteomic and metabolomic changes after ATR inhibition in irradiated MOLT-4 cells.

Authors:  Barbora Šalovská; Hana Janečková; Ivo Fabrik; Radana Karlíková; Lucie Čecháková; Martin Ondrej; Marek Link; David Friedecký; Aleš Tichý
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

Review 9.  Phytochemicals: Potential Therapeutic Modulators of Radiation Induced Signaling Pathways.

Authors:  Bimal Prasad Jit; Biswajita Pradhan; Rutumbara Dash; Prajna Paramita Bhuyan; Chhandashree Behera; Rajendra Kumar Behera; Ashok Sharma; Miguel Alcaraz; Mrutyunjay Jena
Journal:  Antioxidants (Basel)       Date:  2021-12-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.